Stay updated on Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.

Latest updates to the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe revision tag on the page was updated from v3.5.3 to v3.5.4, indicating a maintenance update to the page. This update does not change the study data or essential information presented.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page’s footer/version indicator has been updated from Revision v3.5.2 to v3.5.3, reflecting a site release rather than a modification to the clinical trial information.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check77 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check91 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check113 days agoChange DetectedThe change updates the page revision from v3.4.1 to v3.4.2, with no observed changes to study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.